IDSA on X: New in CID: A #dengue vaccine candidate was efficacious against symptomatic dengue in children and adolescents over 3 years post-vaccination across 8 endemic countries. 📄: #IDSAJournals #ClinInfectDis

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of

Streptococcus pneumoniae Invasive Disease, 2017 - MN Dept. of Health

Efficacy of a Tetravalent Dengue Vaccine in Children in Latin

Four-year safety follow-up of the tetravalent dengue vaccine

By Ahmed Khaled Vaccine team Pfizer KSA - ppt download

Incidence of invasive pneumococcal disease in children with

Immune profile and responses of a novel dengue DNA vaccine

Dengue Vaccine: Considerations before Rollout in Colombia

Pre-vaccination screening strategies for the use of the CYD-TDV

Dengue Vaccine: Recommendations of the Advisory Committee on

Frontiers Current Development and Challenges of Tetravalent Live

The Impact of the Newly Licensed Dengue Vaccine in Endemic